Efficacy of Antenatal Corticosteroids According to Maternal and Perinatal Factors: A Retrospective Cohort Study

Abstract

Objective The aim of this study is to evaluate the impact of multiple pregnancies, maternal obesity, and preeclampsia on the effect of antenatal steroids on neonatal respiratory distress syndrome (RDS).

Study Design The retrospective cohort study was performed in a level III maternity ward. Population was composed of mother–infant pairs. We included inborn infants < 34 weeks gestation, hospitalized in our neonatal intensive care unit, and mothers delivering before 34 weeks gestation and hospitalized before delivery. Primary measurement outcome was RDS.

Results A total of 1,173 subjects were included: 535 mothers and 638 preterm infants. Antenatal corticosteroid (ACS) doses and pulmonary surfactant doses were negatively correlated (r = −0.15, p = 0.0002). Multiple logistic regression: lower gestational age and cesarean section were significantly associated with RDS in single pregnancies (odds ratio [OR], 95% confidence interval [CI]): 2.0 (1.7–2.4) and 3.6 (1.8–7.1), respectively; only gestational age was associated with RDS in twin or higher-order pregnancies: 2.7 (1.9–4.1) and 1.8 (0.6–5.4), respectively. Preterm infants of obese women did not receive more pulmonary surfactant than other preterm infants: OR = 0.67 (0.13–1.40), neither did those born to women with hypertension or preeclampsia.

Conclusion More ACS doses were associated with less pulmonary surfactant doses. Cesarean section and low gestational age increased the risk of RDS, independently from ACS administration, but maternal obesity and multiple pregnancies did not.

Keywords

antenatal corticosteroids - respiratory distress syndrome - preterm infants - obesity - preeclampsia

• References

• 1 EURO-PERISTAT Project with SCPE and EUROCAT. European Perinatal Health Report: the health and care of pregnant women and babies in Europe en 2010. Available at: www.europeristat.com . Accessed July 20, 2014
• 2 Avery ME, Mead J. Surface properties in relation to atelectasis and hyaline membrane disease. AMA J Dis Child 1959; 97 (5, Part 1): 517-523
• 3 Liggins GC. Premature delivery of fœtal lambs infused with glucocorticoids. J Endocr 1969; 45 (4) 515-523
• 4 Liggins GC, Howie RN. A controlled trial of antepartum glucocorticoid treatment for prevention of the respiratory distress syndrome in premature infants. Pediatrics 1972; 50 (4) 515-525
• 5 Crowley PA. Antenatal corticosteroid therapy: a meta-analysis of the randomized trials, 1972 to 1994. Am J Obstet Gynecol 1995; 173 (1) 322-335
• 6 Chauhan SP, Scardo JA, Hayes E, Abuhamad AZ, Berghella V. Twins: prevalence, problems, and preterm births. Am J Obstet Gynecol 2010; 203 (4) 305-315
• 7 Roberts D, Dalziel S. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev 2006; 19 (3) CD004454
• 8 Yudkin PL, Aboualfa M, Eyre JA, Redman CW, Wilkinson AR. New birthweight and head circumference centiles for gestational ages 24 to 42 weeks. Early Hum Dev 1987; 15 (1) 45-52
• 9 Crowther CA, Haslam RR, Hiller JE, Doyle LW, Robinson JS ; Australasian Collaborative Trial of Repeat Doses of Steroids (ACTORDS) Study Group. Neonatal respiratory distress syndrome after repeat exposure to antenatal corticosteroids: a randomised controlled trial. Lancet 2006; 367 (9526) 1913-1919
• 10 Ballabh P, Lo ES, Kumari J , et al. Pharmacokinetics of betamethasone in twin and singleton pregnancy. Clin Pharmacol Ther 2002; 71 (1) 39-45
• 11 Turrentine MA, Wilson PD, Wilkins IA. A retrospective analysis of the effect of antenatal steroid administration on the incidence of respiratory distress syndrome in preterm twin pregnancies. Am J Perinatol 1996; 13 (6) 351-354
• 12 Murphy DJ, Caukwell S, Joels LA, Wardle P. Cohort study of the neonatal outcome of twin pregnancies that were treated with prophylactic or rescue antenatal corticosteroids. Am J Obstet Gynecol 2002; 187 (2) 483-488
• 13 Gyamfi C, Mele L, Wapner RJ , et al; Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. The effect of plurality and obesity on betamethasone concentrations in women at risk for preterm delivery. Am J Obstet Gynecol 2010; 203 (3) 219.e1-219.e5
• 14 Kuk JY, An JJ, Cha HH , et al. Optimal time interval between a single course of antenatal corticosteroids and delivery for reduction of respiratory distress syndrome in preterm twins. Am J Obstet Gynecol 2013; 209 (3) 256.e1-256.e7
• 15 NIH. Effect of corticosteroids for fetal maturation on perinatal outcomes. NIH Consens Statement 1994; 12 (2) 1-24
• 16 ACOG Committee on Obstetric Practice. ACOG Committee Opinion No. 475: antenatal corticosteroid therapy for fetal maturation. Obstet Gynecol 2011; 117 (2 Pt 1): 422-424
• 17 Wapner RJ, Sorokin Y, Thom EA , et al; National Institute of Child Health and Human Development Maternal Fetal Medicine Units Network. Single versus weekly courses of antenatal corticosteroids: evaluation of safety and efficacy. Am J Obstet Gynecol 2006; 195 (3) 633-642
• 18 Bonanno C, Fuchs K, Wapner RJ. Single versus repeat courses of antenatal steroids to improve neonatal outcomes: risks and benefits. Obstet Gynecol Surv 2007; 62 (4) 261-271
• 19 Asztalos EV, Murphy KE, Willan AR , et al; MACS-5 Collaborative Group. Multiple courses of antenatal corticosteroids for preterm birth study: outcomes in children at 5 years of age (MACS-5). JAMA Pediatr 2013; 167 (12) 1102-1110
• 20 Werner EF, Han CS, Savitz DA, Goldshore M, Lipkind HS. Health outcomes for vaginal compared with cesarean delivery of appropriately grown preterm neonates. Obstet Gynecol 2013; 121 (6) 1195-1200